A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease
Clinical trial NCT06734234 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06734234
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-11
- Primary completion
- 2027-07-23
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.